ZORZON, MARINO
 Distribuzione geografica
Continente #
NA - Nord America 6.543
AS - Asia 3.204
EU - Europa 2.783
SA - Sud America 478
AF - Africa 43
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 13.062
Nazione #
US - Stati Uniti d'America 6.501
SG - Singapore 1.313
CN - Cina 804
UA - Ucraina 788
IT - Italia 504
BR - Brasile 406
HK - Hong Kong 385
SE - Svezia 305
FI - Finlandia 248
TR - Turchia 225
KR - Corea 196
GB - Regno Unito 175
VN - Vietnam 135
PL - Polonia 124
FR - Francia 122
IE - Irlanda 116
BG - Bulgaria 115
RU - Federazione Russa 115
DE - Germania 79
IN - India 42
NL - Olanda 25
AR - Argentina 22
BE - Belgio 21
AT - Austria 19
BD - Bangladesh 19
CA - Canada 18
ZA - Sudafrica 17
IQ - Iraq 16
ID - Indonesia 14
MX - Messico 14
EC - Ecuador 13
JP - Giappone 12
MA - Marocco 11
IR - Iran 10
PY - Paraguay 10
CO - Colombia 9
CH - Svizzera 7
CL - Cile 6
AU - Australia 5
JO - Giordania 5
EG - Egitto 4
OM - Oman 4
PE - Perù 4
TN - Tunisia 4
AL - Albania 3
BO - Bolivia 3
DK - Danimarca 3
DZ - Algeria 3
ES - Italia 3
JM - Giamaica 3
KZ - Kazakistan 3
NP - Nepal 3
PK - Pakistan 3
PS - Palestinian Territory 3
UZ - Uzbekistan 3
VE - Venezuela 3
BY - Bielorussia 2
EU - Europa 2
HN - Honduras 2
KE - Kenya 2
LT - Lituania 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PT - Portogallo 2
SA - Arabia Saudita 2
SN - Senegal 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AQ - Antartide 1
AZ - Azerbaigian 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
MY - Malesia 1
PA - Panama 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
Totale 13.062
Città #
Fairfield 748
Singapore 711
Jacksonville 673
Woodbridge 640
Ashburn 545
Wilmington 417
Houston 410
Ann Arbor 401
Hong Kong 385
Chandler 341
Seattle 298
Hefei 294
Cambridge 272
Princeton 228
Izmir 214
Beijing 199
Seoul 195
Boardman 151
Santa Clara 119
Sofia 115
Dublin 114
Zgierz 113
Columbus 104
Buffalo 92
Dallas 80
Milan 80
Moscow 79
Los Angeles 73
San Diego 49
Verona 48
Ho Chi Minh City 45
Dearborn 34
São Paulo 30
Hanoi 28
Chicago 25
Bremen 23
Norwalk 23
The Dalles 23
Brussels 21
Trieste 21
Washington 20
Helsinki 18
Frankfurt am Main 16
San Jose 16
Venezia 16
Düsseldorf 14
Brooklyn 12
London 12
Mumbai 11
New York 11
Phoenix 11
Rio de Janeiro 11
Auburn Hills 10
Denver 10
Johannesburg 10
Nuremberg 10
Tokyo 10
Warsaw 10
Munich 9
Nanjing 9
Rome 9
Brasília 8
Casablanca 8
Guangzhou 8
Kunming 8
Toronto 8
Belo Horizonte 7
Quito 7
Redondo Beach 7
Vienna 7
Boston 6
Dhaka 6
Haiphong 6
Salvador 6
San Mateo 6
Zhengzhou 6
Amman 5
Augusta 5
Bexley 5
Carosino 5
Da Nang 5
Hải Dương 5
Jinan 5
Leawood 5
Portsmouth 5
San Francisco 5
Secaucus 5
Sorocaba 5
Tianjin 5
Amsterdam 4
Ankara 4
Baghdad 4
Can Tho 4
Cape Town 4
Chennai 4
Des Moines 4
Goiânia 4
Ipatinga 4
Joinville 4
L’Aquila 4
Totale 8.929
Nome #
Altered serum content of brain-derived neurotrophic factor isoforms in multiple sclerosis. 273
Optic Nerve and its Arterial-Venous Vascularization: An Ultrasonologic Study in Multiple Sclerosis Patients and Healthy Controls. 223
Functional MRI during the execution of a motor task in patients with multiple sclerosis and fatigue. 219
Bilingual aphasia and subcortical-cortical lesions. 211
Ultrasound findings of the optic nerve and its arterial venous system in multiple sclerosis patients with and without optic neuritis vs. healthy controls. 193
Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study. 183
Mielite recidivante:esordio clinico di neuromielite ottica? 177
Acute encephalopathy and polyneuropathy after disulfiram intoxication. 175
MMP-9 microsatellite polymorphism and multiple sclerosis. 169
Acute akinesia, an unusual complication in Parkinson’s disease: a case report 168
Is gadolinium enhancement predictive of the development of brain atrophy in multiple sclerosis? A review of the literature. 166
Interferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy. 163
Chronic bilateral electrical stimulation of the subthalamic nucleus for the treatment of advanced Parkinson's disease 161
Depressive symptoms and MRI changes in multiple sclerosis 159
CORRELATION OF SEXUAL DYSFUNCTION AND BRAIN MAGNETIC RESONANCE IMAGING IN MULTIPLE SCLEROSIS 159
HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis. 158
Gene-environment interactions between HLA B7/A2, EBV antibodies are associated with MRI injury in multiple sclerosis. 153
A longitudinal study of brain atrophy and cognitive disturbances in early phase of relapsing-remitting multiple sclerosis 152
Immediate prognosis of primary intracerebral hemorrhage using an easy model for the prediction of survival. 152
A longitudinal study of quality of life and side effects in patients with Multiple Sclerosis treated with Interferon beta-1a. 151
Short-term brain atrophy changes in relapsing-remitting multiple sclerosis. 149
HLA GENOTYPES AND DISEASE SEVERITY ASSESSED BY MAGNETIC RESONANCE IMAGING FINDINGS IN PATIENTS WITH MULTIPLE SCLEROSIS. 147
Effect of intravenous methylprednisolone in the number, size and confluence of plaques in relapsing-remitting multiple sclerosis. 147
Outcome of medication overuse headache after abrupt in-patient withdrawal. 145
SEXUAL DYSFUNCTION IN MULTIPLE SCLEROSIS. II. CORRELATION ANALYSIS 144
Effect of intravenous methylprednisolone on the number, size and confluence of plaques in relapsing-remitting multiple sclerosis. 142
Trigeminal neuralgia due to contralateral meningioma of the posterior cranial fossa. 142
Incidence and prevalence of myasthenia gravis in the county of the coast and Gorski kotar, Croatia, 1976 through 1996. 142
Headache induced by Chronic substance use:analysis of medication overused and minimum dose required to induce headache. 137
Sexual dysfunction in multiple sclerosis: a 2-year follow-up study 136
SEXUAL DYSFUNCTION IN MULTIPLE SCLEROSIS. A CASE-CONTROL STUDY. I. FREQUENCY AND COMPARISON OF GROUPS 135
Proton magnetic resonance spectroscopy during transient global amnesia 135
Long-term effects of intravenous high dose methylprednisolone pulses on bone mineral density in patients with multiple sclerosis. 134
Positivity of cytomegalovirus antibodies predicts a better clinical and radiological outcome in multiple sclerosis patients. 133
Nontraumatic headache in the Emergency Department: a survey in the province of Trieste. 132
Efficacia del mesoglicano nella terapia della placca ateromasica dei vasi epiaortici 131
OLFACTORY LOSS IN MULTIPLE SCLEROSIS 128
Clinical surveillance of patients with multiple sclerosis 125
Effect of MRI coregistration on serial short-term brain volume changes in multiple sclerosis. 124
Prevalence of migraine in Croatia: a population-based survey. 123
Development of myasthenia gravis during interferon-alpha treatment for anti-HCV positive chronic hepatitis. 123
Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS 121
Familial and environmental risk factors in Parkinson's disease: a case control study in North-East Italy. 121
Sclerosi multipla in overlap con sindrome di Sjogren 120
Incidence and prevalence of motor neuron disease in Coastal and Mountanious Regions, Croatia, 1984-1993. A preliminary survey. 119
Aritmie cardiache ed ischemia cerebrale acuta. Studio con monitoraggio Holter 119
Sexual dysfunction in multiple sclerosis. A MRI, neurophysiological and urodynamic study 118
Risk factors of multiple sclerosis:a case-control study. 118
Case Report: Coexistence of SUNCT and Hypnic Headache in the Same Patient 118
Central nervous system atrophy in Multiple Sclerosis: Introduction. 117
MRI TECHNIQUES AND COGNITIVE IMPAIRMENT IN EARLY PHASE OF RELAPSING-REMITTING MULTIPLE SCLEROSIS 117
Hyperglycemia at ischemic stroke onset as prognostic factor. 117
Migraine and tension-type headache in Croatia: a population-based survey of precipitating factors. 117
Epstein-Barr Virus is Associated with Gray Matter Atrophy in Multiple Sclerosis 116
Osteopontin gene haplotypes correlate with multiple sclerosis development and progression. 115
Beta 2-microglobulin level is not a marker of disease activity in Multiple Sclerosis. 114
Transient global amnesia and transient ischemic attack. Natural history, vascular risk factors, and associated conditions. 114
Concordance of carotid bruit and positivity of computerized digital angiography of the epiaortic vessels in carotid stenotico-occlusive pathology 112
Atrial fibrillation and acute ischemic cerebrovascular disease. Study of 500 cases of cerebral infarction and transient cerebral ischemic attacks 111
Approccio multidisciplinare alla Sclerosi Multipla. SPSM-RIabilitazione 110
Depression and anxiety in multiple sclerosis. A clinical and MRI study in 95 subjectsJ 109
Treatment of multiple sclerosis. The present and the future. Study Group on Diagnosis and Therapy of Multiple Sclerosis 109
Hypnic headache:rapid and long-lasting response to prednisone in two new cases. 108
Persistent aura without infarction:description of the first case studied with both brain SPECT and perfusion MRI. 107
Cysts of the atlantoaxial joint: excellent long-term outcome after posterolateral surgical decompression. Report of two cases. 106
Reproducibility and accuracy of quantitative magnetic resonance imaging techniques of whole-brain atrophy measurement in multiple sclerosis. 105
Aspetti epidemiologici e clinici dello stroke. 105
Magnetic resonance imaging techniques as predictors of cognitive impairment in multiple sclerosis 103
Trattamento con cicli di megadosi di metilprednisolone in pazienti affetti da sclerosi multipla cronico-progressiva: valutazione clinica a tre anni 103
Proton magnetic resonance spectroscopy study of ischemia in intracerebral hemorrhage 98
Update sul Teriflunomide 97
Use of ticlopidine in patients with acute non-embolic cerebral infarcts 94
Donna e Sclerosi Multipla. I disturbi della sfera sessuale nelle pazienti con sclerosi multipla. 93
Diagnosi e gestione del paziente con sclerosi multipla. Il paziente CIS 92
Il management del paziente di nuova diagnosi. La comunicazione della diagnosi. 90
L'aderenza alla terapia nella sclerosi multipla. Il punto di vista del medico 90
THE USE OF STANDARDIZED INCIDENCE AND PREVALENCE RATES IN EPIDEMIOLOGICAL STUDIES ON MULTIPLE SCLEROSIS. A META-ANALYSIS STUDY 89
Increased density in the middle cerebral artery by nonenhanced computed tomography. Prognostic value in acute cerebral infarction. 89
Disabilità e Qualità della Vita nelle persone colpite da Sclerosi Multipla 87
Side-effects and changes in systemic arterial pressure after administration of a single dose of lorazepam 86
La rieducazione equestre: una possibilità riabilitativa 86
Fattori prognostici nell'emorragia cerebrale primitiva sopratentoriale 86
Focus on:ECTRIMS e SIN 2006 85
Discordanza tra attività di malattia clinica e in risonanza magnetica 84
Terapia antiossidante nell’ictus ischemico acuto 82
Relationship between central nervous system atrophy and genetic-immunological markers in Multiple Sclerosis 81
The blood level of uric acid as a risk factor in transient cerebral ischemic attacks and in non-embolic acute cerebral infarct 81
Familial nature of acute cerebral vasculopathies of the ischemic type 81
Olfactory dysfunction and extent of white matter abnormalities in multiple sclerosis. A clinical and MRI study 78
Hematocrit value and hemoglobin concentration as possible risk factors in non-embolic acute cerebral infarcts 78
Frontal parenchimal atrophy measures in multiple sclerosis. 77
Gaucher’s disease with Parkinson’s disease: Clinical and pathological aspects 77
Hematocrit and hemoglobin in the pathogenesis of transient cerebral ischemic attacks 76
Ticlopidine and pentoxifylline in acute cerebral infarct. Clinical study on 151 patients 76
Ematocrito, emoglobina, numero di globuli rossi e bianchi in rapporto al rischio di insorgenza delle vasculopatie cerebrali acute di tipo ischemico 76
Il morbo di Parkinson 76
Prevention and therapy of delirium tremens with tiapride 74
Fumo di sigaretta e rischio d'insorgenza delle vasculopatie cerebrali acute di tipo ischemico 74
Normalized regional brain atrophy measures in multiple sclerosis 73
Dyslipidemias and ischemic cerebral vasculopathies 73
Totale 12.167
Categoria #
all - tutte 42.554
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.554


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021654 0 0 0 0 0 0 119 145 27 149 64 150
2021/2022852 28 95 12 92 4 32 31 58 143 106 100 151
2022/20231.175 136 68 130 142 117 255 29 89 153 3 43 10
2023/2024761 27 29 35 57 132 44 45 236 6 33 77 40
2024/20251.799 10 95 74 170 270 211 70 96 245 115 138 305
2025/20262.487 275 399 598 489 324 384 18 0 0 0 0 0
Totale 13.105